GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (OTCPK:DSRLF) » Definitions » EV-to-EBIT

Diasorin SpA (Diasorin SpA) EV-to-EBIT : 27.48 (As of May. 16, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Diasorin SpA's Enterprise Value is $6,824 Mil. Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $248 Mil. Therefore, Diasorin SpA's EV-to-EBIT for today is 27.48.

The historical rank and industry rank for Diasorin SpA's EV-to-EBIT or its related term are showing as below:

DSRLF' s EV-to-EBIT Range Over the Past 10 Years
Min: 10.58   Med: 19.72   Max: 51.24
Current: 27.52

During the past 13 years, the highest EV-to-EBIT of Diasorin SpA was 51.24. The lowest was 10.58. And the median was 19.72.

DSRLF's EV-to-EBIT is ranked worse than
60.78% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.47 vs DSRLF: 27.52

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Diasorin SpA's Enterprise Value for the quarter that ended in Dec. 2023 was $6,319 Mil. Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $248 Mil. Diasorin SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.93%.


Diasorin SpA EV-to-EBIT Historical Data

The historical data trend for Diasorin SpA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA EV-to-EBIT Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.77 27.64 24.06 21.94 25.42

Diasorin SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.92 18.04 19.07 25.42 -

Competitive Comparison of Diasorin SpA's EV-to-EBIT

For the Diagnostics & Research subindustry, Diasorin SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's EV-to-EBIT falls into.



Diasorin SpA EV-to-EBIT Calculation

Diasorin SpA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6823.886/248.314
=27.48

Diasorin SpA's current Enterprise Value is $6,824 Mil.
Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $248 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA  (OTCPK:DSRLF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Diasorin SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=248.314/6318.627208
=3.93 %

Diasorin SpA's Enterprise Value for the quarter that ended in Dec. 2023 was $6,319 Mil.
Diasorin SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $248 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diasorin SpA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA (Diasorin SpA) Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.